The structure-activity relationship study on the pyrimidone series of dopamine D1 receptor positive allosteric modulators (PAMs) was just published in Bioorganic and Medicinal Chemistry Letters; many thanks to Prashi, Kadee and our collaborators in the Sibley Lab for all their … Read more

We are excited to share the initial preclinical results on our anti-HCV lead compound, fluoxazolevir, in Nature Microbiology. Many thanks to our collaborators who made this possible!

We are excited to welcome two new post-doctoral scholars to the team, Amber Kelley and David Rogers. Amber joins us from the Petersen Lab at UNC, Greensboro to work on the dopamine modulators project. David joins us from the Lamar … Read more

We are excited to see our long-standing collaboration with the Sibley Lab at NINDS to develop selective D3 dopamine receptor agonists published in The Journal of Medicinal Chemistry. Congratulations to all the many contributors to this project!

Disha has started her new position as medicinal chemist at Neurocrine Biosciences. We will miss her here and wish her all the best on the West Coast!

Disha successfully competed for a UNC Office of Postdoctoral Affairs travel award to support presentation of her work at the 2019 Heterocyclic Compounds Gordon Research Conference in Newport, Rhode Island. Way to go, Disha!

Forest Koenigsberg has joined the Dopamine Modulators Team as a Research and Scholarship in Pharmacy (RASP) Program scholar. We’re glad to have you here and hope you enjoy your experience doing early-stage drug discovery.

Disha Gandhi has joined the lab from Marquette University to work on the dopamine modulators project. Welcome to UNC and Chapel Hill, Disha!

Feijun Wang has joined the Team, working on the Natural Product-like Library Project. We are happy you’re here and hope you enjoy your time at UNC.

Jay is moving on to the next stage of his career and accepted a position with Adesis Inc.—Good luck, Jay!